Cartherics’ Chairman Bob Moses has over 40 years of executive experience in life science companies. You name it, he’s been there: Eli Lilly, ICI Australia, CSL Limited, Freehills, Amrad, Meditech, Daratech, Australian Stem Cell Centre, TGR Biosciences, and two Cooperative Research Centres.
Based on his depth of […]
MEDIA RELEASE
8 May 2019 Parties use science to set themselves apart ….
The major parties have laid out their science and technology platform for Australian voters, with clear differences in their approach and vision for empowering the solutions sector.
Responding to a survey from peak body Science & Technology Australia (STA), the Coalition, the Labor Party and the Greens have all […]
The Technology has wowed the field by all but obliterating some patients’ blood cancers, but sold malignancies present new challenges
The Scientist
1 April 2019 Kerry Grens
https://www.the-scientist.com/features/the-next-frontier-of-car-t-cell-therapy–solid-tumors-65612
A long way into the quest to vanquish cancer, our ears strain to hear the words, “Cancer is cured”- a yearning that can cloud our judgment.
The Scientist
Apr 1, 2019
BOB GRANT Editor-in-Chief
Cancer has bedeviled humankind since long before scientists even had a word to describe the dread disease. It is therefore understandable that our ears […]
by Alan Trounson
Hear Alan Trounson discuss the issue Saturday 6 April at 12 noon on ABC Radio National’s The Science Show.
A few weeks ago, 18 scientists from seven countries took me back forty years to a time when I was involved with the first IVF birth in Australia. Why? The scientists, writing in the journal […]
April 01, 2019
After 10 years in remission, Derek Ruff’s cancer returned, this […]
Tom Long’s battle with Multiple Myeloma
Lisa Wilkinson interviewed Aussie Actor and multiple myeloma patient Tom Long on The Sunday Project to help raise awareness for blood cancer and the need for more research in Australia. The story is heartbreaking, Tom is hanging on to hope. Hope that a CAR-T cell treatment that he has to […]
Ms Rasa Islam is Cartherics’ first full-time PhD student. She’s joining the team under a prestigious Cooperative Research Centre (CRC) Project Grant entitled “Allogeneic Stem Cell Cancer immunotherapies”.
As part of the CRC-P Program, Cartherics offers high calibre students PhD research programs of study that include international level research training, […]
THE promise is remarkable: a new class of affordable, effective cancer treatments beyond surgery, chemotherapy, biologicals and radiation. Imagine cancer specialists being able to select from a range of treatments to supercharge a patient’s immune system, helping it eliminate cancer.
This is not a distant vision. It is happening right here, right now. A research team, […]
Cartherics’ mission is the development of novel, immune cell therapy products for the treatment of cancer, endometriosis and Alzheimer’s disease.
Stay informed about our latest news and developments
© Copyright 2022 | Cartherics Pty ltd
